SEC Form 4 · accession 0001225208-17-011120
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David A Pierce
Officer — SVP and President, Endoscopy
Period of report
Jun 9, 2017
Accepted (ET)
Jun 12, 2017 · 4:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 9, 2017 | M | 9,500 | $13.08 | A | 33,701 | D | |
| Common Stock | Jun 9, 2017 | M | 4,062 | $7.39 | A | 37,763 | D | |
| Common Stock | Jun 9, 2017 | S | 13,562 | $28.00 | D | 24,201 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $13.08 | Jun 9, 2017 | M | 9,500 | D | — | Feb 24, 2024 | Common Stock | 9,500 | 26,929 | D |
| Stock Option (Right to Buy)F3 | $7.39 | Jun 9, 2017 | M | 4,062 | D | — | Feb 28, 2023 | Common Stock | 4,062 | 42,934 | D |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
- F2Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.
- F3Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.